Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

App alerts when loved ones are near: a new way to fight social isolation in dementia?

NCT ID NCT07773493

Symptom relief Sponsor: University of Minnesota Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This trial tests a mobile app called the Social Reminder System, designed to help people with memory concerns stay socially engaged. The app sends reminders on a home tablet when a trusted friend or family member is nearby, potentially encouraging more visits and interactions. Researchers will compare the app to usual care in about 100 pairs of people with memory concerns and their caregivers over six months, measuring social engagement, loneliness, and caregiver burden.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Social Reminder System app
What this could lead to
If effective, this app could help people with memory concerns stay socially connected and reduce the stress and burden on their caregivers.
What could go wrong
This is a relatively small, early-stage trial, and the app's benefits may not be significant or may not apply to all users. There is also a risk that the technology could be difficult for some participants to use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Persons with memory concerns must be English speaking. * Persons with memory concerns must self-report a healthcare provider visit due to memory concerns or memory related diagnosis by a physician or other qualified health care provider consistent with having mild-to-moderate memory impairment. * Persons with memory concerns must be over the age of 65. * Persons with memory concerns must be able to formally consent or assent to participate in the study. * Persons with memory concerns must have internet access. * Care partners of persons with memory concerns must speak English. * Care partners must be 18 years of age and over. * Care partners must self-identify as the primary caregiver for the person with memory concerns. * Care partners must indicate a willingness to use the Social Reminder System as well as to being randomized to a control group. * Care partners must have a mobile phone with internet access in order to install and use the care partner app. Exclusion Criteria: * Those who do not meet the criteria above will be excluded. * Persons with memory concerns with severe or no dementia are not eligible. * Individuals who score below 6 and above 24 on the TICS-40 will not be eligible.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Caregiver burden are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alzheimer disease Caregiver Burden cognitive disorder Cognitive Dysfunction dementia Memory Disorders Social Isolation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Caregiver burden Dementia Memory disorders Mild cognitive impairment Social isolation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Of Minnesota

    Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.